OBJECTIVE: To examine the contribution of the substitution of arginine for tryptophan at amino acid position 64 (Trp64Arg) of the b b 3 -adrenergic receptor to body weight and weight-related factors in healthy, premenopausal women. SUBJECTS: Five hundred and ®ve healthy, premenopausal women 44±50 y, body mass index (BMI) 20±34 kg/m 2 . MEASUREMENTS: Subjects were genotyped for the Trp64Arg substitution using restriction fragment length polymorphism (RFLP) analysis. Measurements for weight and weight-related factors (for example, weight, waist-hip ratio, lipid levels) were also taken. RESULTS: Two women were homozygous Arg/Arg, 75 women were heterozygous Trp/Arg, and 428 women were homozygous Trp/Trp. The frequency of the Arg substitution was 0.078. When subjects with and without the arginine substitution were compared, no signi®cant differences were found on measures of weight or weight-related risk factors. CONCLUSION: The results con®rm previous studies suggesting that the Trp64Arg substitution of the b b 3 -adrenergic receptor is not related to weight or weight-related phenotypes in healthy, premenopausal women.
Introduction
Obesity is a major risk factor for a number of diseases, including coronary heart disease (CHD) and noninsulin-dependent diabetes (NIDDM). Obesity results from a complex interaction between environmental and genetic contributors. 1 Because of genetic heterogenity and multiple environmental covariates, it has been dif®cult to identify speci®c genes responsible for the development of obesity, although several candidate genes have been suggested. 2 One of these is the b 3 -adrenergic receptor (B3AR) gene which is expressed in visceral adipose tissue and is thought to contribute to increased lipolysis and thermogenesis. 3, 4 Walston et al 5 identi®ed a nucleotide substitution which results in an amino acid change from tryptophan to arginine (Trp64Arg) in the predicted ®rst intracellular loop of the B3AR, and suggested an association between this substitution and early onset of NIDDM among Pima Indians. Two other groups simultaneously published data associating the Trp64Arg substitution with higher waist-hip ratios and 2 h glucose levels in Finns 6 and increased capacity to gain weight in morbidly obese French. 7 Several additional studies examining the Trp64Arg substitution in the b 3 AR have followed, but the results have been inconsistent. 8±16 This study assessed the role of the Trp64Arg substitution as a contributor to body weight and weight-related risk factors in a sample of healthy, middle-aged women.
Methods

Subjects
The sample consists of 505 women 44±50 y. These women are currently participating in the Women's Healthy Lifestyle Project (WHLP), which is designed to assess the effectiveness of a dietary and behavioral intervention in preventing weight gain and increased cholesterol levels after menopause. Eligibility requirements were: that the women be premenopausal (de®ned as less than 3 months amenorrhea in the 6 months prior to initial intervention); not having surgically induced menopause; not taking any lipid-lowering agents, insulin, thyroid, anti-hypertensive or psychotropic medications; not treated for cancer in the past 5 y; and not having participated in a commercial weight reduction program within the past 4 months. In addition, all participants were required to have a body mass index (BMI) between 20 and 34 kg/ m 2 ; fasting glucose concentration was to be lower than 140 mg/dl; and low-density lipoprotein-cholesterol (LDL-C) and total cholesterol ranging between 80 and 160 mg/dl, and 140 and 260 mg/dl, respectively.
Trp64Arg genotyping
The 251-bp segment of the gene containing the Trp64Arg substitution was ampli®ed by polymerase chain reaction (PCR) from genomic DNA extracted from leukocytes using the primers 5
H -ACACCAGTG-GGCTGCCAGGGGT (forward) and 5
H -AGCTCG-CAGCCAGTGGCGCCCAACGG (reverse). PCR was carried out essentially as described by Saiki et al. 17 Digestion of the amplicon with the enzyme BstN1 followed by electrophoresis in 2% agarose gel resulted in fragments of 113, 63 and 61 in homozygous Trp/Trp; 174, 113, 63 and 61 in heterozygotes and 174 and 63 in homozygous Arg/Arg.
Dependent measures
All blood work was completed in the fasting state. Total serum cholesterol, 18 high-density lipoprotein cholesterol (HDL-C) and its subfractions, 19 triglycerides 20 and glucose were measured by the Heinz Nutrition Laboratory at the Graduate School of Public Health, University of Pittsburgh, which is certi®ed by the Center for Disease Control. Glucose was determined qualitatively using an Abbott VP supersystem spectrophotometer (Abbott Laboratories, Abbott Park, Il) 21 . Insulin was measured by radioimmunoassay. LDL-C was estimated using the Friedewald equation. 21 BMI was calculated by dividing weight in kilograms by height in meters squared (kg/ m 2 ). Waist circumference (at the narrowest part of the torso) and hip circumference (at the level of maximum protrusion of the buttocks) were measured to the nearest 0.1 cm and used to calculate waist-hip ratio (WHR). Skinfold measurements were taken of the triceps, subscapular, iliac crest and thigh with a Lange skinfold caliper. These measurements were used to calculate percent body fat using formulae developed by Jackson et al, 22 which have been shown to accurately estimate percent body fat. Blood pressure was measured by the random zero muddler method. 23 All participants reported their maximum weight ever and their weight at age 20. The difference between these two measurements was used to de®ne weight gain during adulthood. Subjects also reported the presence or absence of NIDDM in ®rst degree relatives.
Statistical Analysis
All analyses were performed using SPSS software for statistical analyses. Differences in allelic frequency were analyzed by chi-square, comparing the frequency of the substitution by ethnicity (AfricanAmerican vs Caucasian vs Other), obesity (BMI`27 kg/m 2 vs BMI ! 27 kg/m 2 ) and family history of diabetes (Yes/No). In addition, a logistic regression analysis was performed to test whether BMI or other obesity-related variables differed in subjects with and without the Trp64Arg substitution. A t-test for independent samples was used for comparison of all other parameters between carriers of the substitution (Arg/Arg and Trp/Arg phenotypes) and non-carriers (Trp/Trp phenotype).
Results
From the sample of 505 women, two were homozygous Arg/Arg, 75 were heterozygous Trp/Arg, and 428 were homozygous Trp/Trp. The allelic frequencies for the Trp and Arg alleles were 0.922 and 0.078, respectively. The allelic frequencies were consistent with Hardy-Weinberg expectation, and were comparable to those previously reported in other Caucasian populations.
5,7,9,10,13±16 Table 1 presents the results of t-tests comparing the subjects with a Trp64Arg substitution of the b 3 AR and those with no substitution for quantitative traits related to body size and morphology, glucose metabolism, lipid metabolism and hypertension. The presence of the Arg substitution was not associated with any measure of body size or weight distribution, glucose metabolism or blood pressure. HDL-C levels were slightly higher among carriers of the Arg allele (62.4 mg/dl) than among non-carriers (58.8 mg/dl; P 0.024). When a Bonferroni adjustment was used to correct for the number of statistical tests performed, this difference was no longer signi®cant. Chi-square analysis of mutation frequency by ethnicity (AfricanAmerican vs Caucasian vs Other), family history of diabetes (Yes/No among ®rst degree relatives) and obesity (BMI ! 27 kg/m 2 vs BMI`27 kg/m 2 ) also demonstrated lack of statistical signi®cance (Table 2) . Likewise, logistic regression analysis showed no differences in BMI, fasting insulin or lipids in those with and without the Trp64Arg substitution.
Two subjects were homozygous Arg/Arg. These women had BMI levels of 27.7 and 21.3 kg/m 2 ; fasting glucose of 92 and 97 mg/dl; and fasting insulin of 14 and 7 mU/ml, respectively. Thus, they appeared similar to the women without the substitution.
Discussion
Discovery of the Trp64Arg polymorphism in the b 3 AR gene has generated several studies examining the contribution of this substitution to various obesityand diabetes-related phenotypes. The ®ndings suggest that the prevalence of this substitution varies substantially according to population, ranging from 7±10% in several Caucasian populations 5,7,9±11,13±16 to 31% in Pima Indians. 5 In the WHLP cohort, the frequency of the Trp64Arg substitution in the b 3 AR (0.078) was similar to other Caucasian populations.
5,7,9±11,13±16
There has been inconsistency regarding the relation between the Trp64Arg substitution and body weight. Two studies performed on Japanese cohorts 8, 12 and one performed on a Danish cohort 13 reported an increased BMI in subjects homozygous Arg/Arg, but no signi®cant difference in BMI in the heterozygotes. Another study found a higher mean BMI in women displaying the substitution but not in men. 10 In contrast, the original three studies did not ®nd an increased BMI in subjects with the substitution, 5, 7 and a growing number of more recent studies are ®nding no association between BMI and the Trp64Arg substitution of the b 3 AR. 9,11,14±16,24,25 This study further supports the evidence that BMI is not associated with this substitution.
The Trp64Arg substitution has also been observed to be related to risk factors related to obesity. For example, one study reported early onset of NIDDM 5, 6 in those with the Trp64Arg, while another study suggested a link between the substitution and the magnitude of weight gained since age 20 y. 7 In addition, one study reported a signi®cantly decreased insulin sensitivity in subjects homozygous for the arginine allele. 13 In the present study, no differences in fasting insulin were observed between the carriers and non-carriers of the Trp64Arg allele. Although sophisticated measures of insulin sensitivity were not collected in this study, fasting insulin levels have been shown to be highly correlated with glucose-clamp measures of insulin sensitivity in nondiabetic subjects. 26 Furthermore, women with the Family history of diabetes was de®ned as having at least one 1st degree relative with NIDDM. b Three subjects are missing data for this question. *All P values were determined using a Pearson's chi-square analysis.
b b 3 -Adrenergic receptor substitution and obesity M Moriarty et al substitution did not have higher waist-hip ratio, weight gain since age 20 y, percent body fat nor any evidence of being at greater risk for NIDDM. We recognize the fact that extremely obese women are underrepresented in our sample and that this particular polymorphism may be more likely to be found in extreme obesity. However, several recent studies containing a higher proportion of subjects with a BMI greater than 30 kg/m 2 have shown similar results in obesity-related factors. 9, 11, 16 Because increased weight is a major risk factor for a variety of common diseases, our goal was to determine whether allelic variation in the b 3 AR is associated with interindividual variation in measures of weight, body morphology or quantitative risk factors for NIDDM or coronary disease in a healthy population of premenopausal women. Our results support the conclusion drawn by Maurie Áge and Bouchard 27 that the Trp64Arg substitution in the b 3 AR is not a signi®cant determinant of BMI in the normal to moderately obese range.
